- Home
- ACHV vs EVC Comparison
ACHV vs EVC Comparison
Compare ACHV & EVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- EVC
- Stock Information
- Founded
- ACHV N/A
- EVC 1996
- Country
- ACHV Canada
- EVC United States
- Employees
- ACHV N/A
- EVC N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- EVC Broadcasting
- Sector
- ACHV Health Care
- EVC Industrials
- Exchange
- ACHV Nasdaq
- EVC Nasdaq
- Market Cap
- ACHV 159.0M
- EVC 185.4M
- IPO Year
- ACHV N/A
- EVC 2000
- Fundamental
- Price
- ACHV $4.98
- EVC $2.20
- Analyst Decision
- ACHV Strong Buy
- EVC Hold
- Analyst Count
- ACHV 4
- EVC 1
- Target Price
- ACHV $15.50
- EVC $1.75
- AVG Volume (30 Days)
- ACHV 112.5K
- EVC 225.1K
- Earning Date
- ACHV 11-07-2024
- EVC 10-31-2024
- Dividend Yield
- ACHV N/A
- EVC 9.03%
- EPS Growth
- ACHV N/A
- EVC N/A
- EPS
- ACHV N/A
- EVC N/A
- Revenue
- ACHV N/A
- EVC $1,126,331,000.00
- Revenue This Year
- ACHV N/A
- EVC N/A
- Revenue Next Year
- ACHV N/A
- EVC N/A
- P/E Ratio
- ACHV N/A
- EVC N/A
- Revenue Growth
- ACHV N/A
- EVC 65.95
- 52 Week Low
- ACHV $3.03
- EVC $1.33
- 52 Week High
- ACHV $5.98
- EVC $4.41
- Technical
- Relative Strength Index (RSI)
- ACHV 56.44
- EVC 58.30
- Support Level
- ACHV $4.85
- EVC $2.05
- Resistance Level
- ACHV $5.13
- EVC $2.35
- Average True Range (ATR)
- ACHV 0.18
- EVC 0.08
- MACD
- ACHV -0.01
- EVC 0.02
- Stochastic Oscillator
- ACHV 43.40
- EVC 58.33
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About EVC Entravision Communications Corporation
Entravision Communications Corp is a global advertising solutions, media, and technology company. Its operations encompass integrated marketing and media solutions, comprised of television, radio, and digital properties and data analytics services. The company operates in television broadcasting, audio broadcasting, and digital media segments. The Company's digital segment, whose operations are located in Europe, Latin America, Asia, the United States, and Africa. The Company's television and audio operations reach and engage U.S. Hispanics in the United States.